179 results on '"Ribbat-Idel, Julika"'
Search Results
2. RudolfV: A Foundation Model by Pathologists for Pathologists
3. Deglycosylation of pathological specimens alters performance of diagnostic PDL1 antibodies
4. DNA methylation-based classification of sinonasal tumors
5. Combining CD3 density and PD-L1 expression into one prognostic factor identifies patients with an exceptional prognosis
6. Intra-tumoral and peripheral PD-1/PD-L1 expression correlation in head and neck cancer
7. First approach to distinguish between cardiac and arteriosclerotic emboli of individual stroke patients applying the histological THROMBEX-classification rule
8. Development and reliability of the histological THROMBEX-classification rule for thrombotic emboli of acute ischemic stroke patients
9. Correction to: Deglycosylation of pathological specimens alters performance of diagnostic PDL1 antibodies
10. Correlation of Intra-tumoral and Peripheral PD-1/PD-L1 Immunity in Head and Neck Cancer
11. Identifying Predictive Biomarkers for Head and Neck Squamous Cell Carcinoma Response
12. In silico analysis reveals EP300 as a panCancer inhibitor of anti-tumor immune response via metabolic modulation
13. DNA methylation-based reclassification of olfactory neuroblastoma
14. Prognostic impact of the loss of E-cadherin and de novo expression of N-cadherin at the invasive front of primary and recurrent oral squamous cell carcinoma
15. Supplementary Figure from Therapy-Related Transcriptional Subtypes in Matched Primary and Recurrent Head and Neck Cancer
16. Supplementary Data from Therapy-Related Transcriptional Subtypes in Matched Primary and Recurrent Head and Neck Cancer
17. Supplementary Table from Therapy-Related Transcriptional Subtypes in Matched Primary and Recurrent Head and Neck Cancer
18. TRIM21 Expression as a Prognostic Biomarker for Progression-Free Survival in HNSCC
19. Correction: Becker et al. Identifying Predictive Biomarkers for Head and Neck Squamous Cell Carcinoma Response. Cancers 2023, 15 , 5597.
20. EP147/#165 Overexpression of the orphan nuclear receptor NR2F6 is associated with an improved survival in endometrial cancer patients
21. 2022-RA-1344-ESGO Endometrial cancer patients with an overexpression of the orphan nuclear receptor NR2F6 show an improved survival
22. TRIM24 Expression as an Independent Biomarker for Prognosis and Tumor Recurrence in HNSCC
23. Increased Abundances of CD16+ Non-Classical Monocytes Accompany with Elevated Monocytic PD-L1 and CD4+ T Cell Disturbances in Oropharyngeal Cancer
24. Elevated LSD1 and SNAIL Expression Indicate Poor Prognosis in Hypopharynx Carcinoma
25. Therapy-Related Transcriptional Subtypes in Matched Primary and Recurrent Head and Neck Cancer
26. CDK7 Predicts Worse Outcome in Head and Neck Squamous-Cell Cancer
27. Spatial Distribution of Immune Cells in Head and Neck Squamous Cell Carcinomas
28. Delta-Like Protein 3 Expression in Paired Chemonaive and Chemorelapsed Small Cell Lung Cancer Samples
29. Correction to: DNA methylation-based reclassification of olfactory neuroblastoma
30. IDH2 R172 Mutations Across Poorly Differentiated Sinonasal Tract Malignancies
31. Recurrent HNSCC Harbor an Immunosuppressive Tumor Immune Microenvironment Suggesting Successful Tumor Immune Evasion
32. Palliative Local Radiotherapy for Advanced Squamous Cell Carcinoma of the Head-and-Neck: Prognostic Factors of Survival
33. A New Survival Score for Patients Scheduled for Palliative Irradiation of Locally Advanced Carcinoma of the Head-and-Neck
34. Performance of Different Diagnostic PD-L1 Clones in Head and Neck Squamous Cell Carcinoma
35. CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCC
36. Immunologic “Cold” Squamous Cell Carcinomas of the Head and Neck Are Associated With an Unfavorable Prognosis
37. Recurrent HNSCC Harbor an Immunosuppressive Tumor Immune Microenvironment Suggesting Successful Tumor Immune Evasion
38. Increased Abundances of CD16 + Non-Classical Monocytes Accompany with Elevated Monocytic PD-L1 and CD4 + T Cell Disturbances in Oropharyngeal Cancer.
39. A randomized trial (RAREST-01) comparing Mepitel® Film and standard care for prevention of radiation dermatitis in patients irradiated for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN)
40. miRNA expression profiling in formalin-fixed and paraffin-embedded placental tissue samples from pregnancies with severe preeclampsia
41. NR2F6 as a Prognostic Biomarker in HNSCC
42. CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCC
43. CD3 and CD20 immune cell densities in primary tumors, lymph node metastasis, and recurrent disease samples of head and neck squamous cell carcinoma.
44. PSMD9 expression correlates with recurrence after radiotherapy in patients with cervical cancer
45. EVI1 as a Marker for Lymph Node Metastasis in HNSCC
46. TRIM24 as an independent prognostic biomarker for prostate cancer
47. Die Kombination aus dichtem T-Zell-Infiltrat und PD-L1 Expression identifiziert Kopf-Hals-Tumor Patienten mit besonders guter Prognose.
48. Korrelation intra-tumoraler und peripherer PD-1/PD-L1 Expression in HNSCC.
49. Primary and recurrent head and neck squamous carcinomas are strikingly different regarding their immune microenvironment
50. TRIM24 as an independent prognostic biomarker for prostate cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.